What Seuss Consulting does

Seuss Consulting B.V. (doing business as Seuss+) is a private, Amsterdam-based life-sciences consultancy founded in 2012 by co-CEOs Sabine Hutchison and Kieran Canisius. The firm helps biotech and pharma sponsors optimize the relationships between their internal teams and the external vendors (CROs, suppliers, technology providers) involved in running clinical trials. Its core intellectual property is the Vendor Relationship Maximization Method (VRMM), a proprietary five-stage methodology — Strategic Blueprint, Foundational Framework, Infrastructure Setup, Optimization, and Pivotal Inflection — supported by a Vendor Evaluation Matrix, a structured Vendor Selection Framework, and a Clinical Systems Analysis (CSA) capability that addresses regulatory compliance including FDA 21 CFR Part 11, ICH GCP, EMA, and MHRA requirements. The company claims 14 years of industry experience, 55+ biotech programs supported, and coverage across 10+ therapeutic areas including oncology, neurology, immunology, and rare disease.

The service catalog is organized entirely around the VRMM lifecycle and includes vendor strategy, market scan, vendor selection, contract negotiation, vendor qualification (GCP/GMP), systems validation, clinical systems implementation and oversight, risk management setup, governance and reporting, vendor oversight, budget and change order management, conflict resolution, and inspection readiness. Seuss+ also offers a free anonymous Clinical Development Vendor Health Check, a three-part vendor selection white paper series, a 'Cut the Chat' podcast, and a monthly Clinical Development Insights newsletter.

Commercially, Seuss+ operates a sales-led enterprise consulting model targeting small to mid-sized biotech sponsors as its primary segment, with secondary reach into pharma sponsors, CROs, and medical device companies. The go-to-market is built on thought leadership (blog, white papers, conference speaking at ISPOR, Bio-Europe, JPM Healthcare Conference, DIA, HBA), a free 30-minute strategic intro call as the lead conversion mechanism, and bespoke project or retainer engagements. Pricing is not publicly disclosed. The firm claims a global reach from its Amsterdam headquarters. The legal entity was formed through a January 2023 merger of Seuss Consulting B.V. and Seuss Recruitment B.V. No external institutional investment has been disclosed.

Name

Seuss Consulting

Legal name

Seuss Consulting BV

Website

https://seuss.plus

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Seuss+ is an Amsterdam-based life-sciences consultancy that helps biotech and pharma sponsors select, contract, and oversee clinical trial vendors through its proprietary five-stage Vendor Relationship Maximization Method (VRMM), serving primarily small and mid-sized biotechs.

Ownership category

akta.pro rank

Product category

Clinical Development Consulting

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

akta.pro secondary industry

Training & Competency Programs for GxP Compliance (HLAGAKAM)

Keywords

• Clinical trial consulting
• Vendor relationship management
• Biotech vendor selection
• Clinical development consulting
• Pharma outsourcing advisory

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Development Consulting Services: Seuss+ generates revenue through professional consulting services delivered on a project or retainer basis. Services span the full VRMM lifecycle: vendor strategy, market scans, vendor selection, contract negotiation, vendor oversight, risk management, governance, and inspection readiness. The firm is described as hands-on and execution-focused, implying deliverable-based or milestone-based engagements rather than passive advisory retainers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels9 records

Core offering

Seuss+ is a life-sciences consultancy that optimizes the relationships between biotech and pharma sponsors and their clinical trial vendors. The firm delivers professional consulting services organized around its proprietary Vendor Relationship Maximization Method (VRMM), a five-stage system that covers vendor strategy, vendor selection, contract negotiation, vendor oversight, risk management, governance, and inspection readiness. The company positions itself as a hands-on execution partner that owns deliverables alongside the sponsor's internal team rather than acting as a passive advisor.

Product overview

Seuss+ is a life-sciences consultancy that operates as a unified advisory platform built around its proprietary Vendor Relationship Maximization Method (VRMM), a five-stage system comprising Strategic Blueprint, Foundational Framework, Infrastructure Setup, Optimization, and Pivotal Inflection stages. The core offering is vendor optimization consulting for biotech and pharma sponsors conducting clinical trials, supported by specialized service modules including Vendor Selection, Contract Negotiation, Vendor Qualification (GCP & GMP), Systems Validation Consulting, Clinical Systems Analysis, Risk Management, Governance & Reporting, Vendor Oversight, and Inspection Readiness. The company also offers proprietary assessment tools (Clinical Development Vendor Health Check), educational content (Cut the Chat Podcast, Clinical Development Insights Newsletter), and white paper resources covering vendor selection best practices and clinical systems compliance. Seuss+ positions itself as hands-on partners who own deliverables, distinguishing itself from passive consultants who only advise.

Differentiator

Problem solved

Functional benefit

Products and services

• Vendor Relationship Maximization Method (VRMM)
• Vendor Strategy
• Market Scan
• Vendor Selection
• Contract Negotiation
• Vendor Qualification (GCP & GMP)
• Systems Validation Consulting
• Study Risk Management Setup
• Governance & Reporting
• Vendor Oversight
• Clinical Systems Analysis (CSA)
• Clinical Systems Implementation and Oversight
• Sponsor & Vendor Team Dynamics Workshop
• Vendor Management
• Budget & Change Order Management
• Risk Management
• Conflict & Collaboration Solutions
• Inspection Readiness
• Clinical Development Vendor Health Check

Quantifiable outcome

• 55+ biotech programs supported through high-stakes phases
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• DiMe (Digital Medicine Society)strategicStrategic or Co-development Partner · 1 January 2025Seuss+ announced a strategic partnership with DiMe's 'Building the Business Case for Digital Endpoints' project. This partnership positions Seuss+ as a consultancy contributing to DiMe's cross-industry initiative to develop the evidence base for digital endpoint adoption in clinical trials. Lauren Alani, Director of Digital Innovation at Seuss+, was also scheduled to speak at a DiMe webinar on Digital Endpoints in Biotech.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• ProPharma Group: Pharmaceutical consulting firm providing regulatory, clinical, compliance and quality services to pharma and biotech sponsors. Closely comparable in regulatory/clinical-services orientation and customer segment.
• PharmaLex (now part of Cencora): Specialist pharma consulting and service provider across regulatory affairs, clinical development and quality/GxP, serving biotech through large pharma. Comparable in clinical-development and GxP focus.
• Dark Horse Consulting Group: Boutique life-sciences consultancy focused on biotech product development, CMC and operations support. Comparable to Seuss+ in size, niche focus and biotech-sponsor customer base.
• Alacrita: Boutique life-sciences consulting firm advising biotech and pharma on commercial, clinical and corporate development strategy. Comparable in size and biotech-sponsor targeting.
• Concept Life Sciences: Contract research and scientific consulting firm supporting pharma/biotech across drug development and regulatory. Comparable as a mid-sized CRO/consulting services peer targeting similar sponsors.

Broad incumbents

• ICON plc: Global CRO and consulting services provider for pharma/biotech including clinical operations, outsourcing strategy and vendor governance. Comparable on clinical-vendor domain, broader service portfolio.
• Parexel International: Large global CRO offering clinical operations, regulatory and consulting services to pharma and biotech. Comparable in clinical-development vendor oversight services, but bundled into a full-service CRO offering.
• MilliporeSigma (BioReliance Regulatory & Compliance Services): Life-science tools and services business offering GxP regulatory, quality and compliance consulting relevant to clinical-trial vendor oversight. Comparable in GxP/QA consulting scope, far broader parent portfolio.
• IQVIA: World's largest CRO with a dedicated Consulting arm advising pharma on R&D operations, vendor strategy and outsourcing. Comparable on vendor-relationship management but at vastly greater scale and breadth.
• Charles River Associates (Life Sciences Practice): Global management consulting firm with a dedicated Life Sciences practice serving pharma, biotech and medtech on commercial, R&D and operations strategy. Comparable in advisory orientation but far broader portfolio than Seuss+.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/seuss-plus-life-science-consulting
• Facebookfacebook.com/seussplus

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seuss Consulting